Identification of a Clinically Relevant Androgen-Dependent Gene Signature in Prostate Cancer

Abstract excerpt

The androgen receptor (AR) is the principal target for treatment of non-organ-confined prostate cancer (PCa). Androgen deprivation therapies (ADT) directed against the AR ligand-binding domain do not fully inhibit androgen-dependent signaling critical for PCa progression. Thus, information that could direct the development of more effective ADTs is desired. Systems and bioinformatics approaches suggest that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hormonal and reproductive studies
• Share to Prostate Cancer Diagnosis and Treatment
• Share to Prostate Cancer Treatment and Research